Cargando…

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?

• Discuss ASCCP guideline. • CIN3 reliable surrogates for cervical cancer? • The Pittsburgh Cervical Cancer Screening Model.

Detalles Bibliográficos
Autores principales:	Austin, R. Marshall, Onisko, Agnieszka, Zhao, Chengquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Cytopathology. Published by Elsevier Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387921/ https://www.ncbi.nlm.nih.gov/pubmed/32839150 http://dx.doi.org/10.1016/j.jasc.2020.07.133

Ejemplares similares

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
por: Barrett, James E., et al.
Publicado: (2022)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

The wages of CIN
por: Yuen, Karen W., et al.
Publicado: (2008)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells
por: Lee, Hee-Sheung, et al.
Publicado: (2013)

Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection
por: van den Helder, Rianne, et al.
Publicado: (2020)

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival
por: Halle, Mari K., et al.
Publicado: (2021)

Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3
por: del Pino, Marta, et al.
Publicado: (2021)

Tincture Cin Honœ Ferrata
por: Sims, Samuel
Publicado: (1853)

Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis
por: Kelly, Helen, et al.
Publicado: (2022)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 or Worse Lesion in Women with a Previous Colposcopy-Guided Biopsy Showing CIN 1
por: Souza, Carlos André Scheler de, et al.
Publicado: (2017)

Vitamin D Receptor Gene Polymorphisms and the Risk of CIN2+ in Shanxi Population
por: Li, Dongyan, et al.
Publicado: (2022)

Individualized Bayesian Risk Assessment for Cervical Squamous Neoplasia
por: Farchoukh, Lama F., et al.
Publicado: (2020)

Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation.
por: Zawislak, A., et al.
Publicado: (2003)

Chronical cervical infections and dysplasia (CIN I, CIN II): Vaginal vitamin D (high dose) treatment: A new effective method?
por: Schulte-Uebbing, C, et al.
Publicado: (2014)

DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
por: Herzog, Chiara, et al.
Publicado: (2022)

Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs
por: Zhao, Dongman, et al.
Publicado: (2020)

A survey of CIN measures across mechanistic models
por: Lynch, Andrew R., et al.
Publicado: (2023)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
por: Andersson, S, et al.
Publicado: (2005)

Quantitative Histopathological Analysis of CIN Sections
por: Baak, Jan P. A.
Publicado: (2006)

Quantitative Histopathological Analysis of CIN Sections
por: Guillaud, Martial, et al.
Publicado: (2006)

Evolution of aneuploidy: overcoming the original CIN
por: Storchova, Zuzana
Publicado: (2018)

Up to your NEK2 in CIN
por: Seachrist, Darcie D., et al.
Publicado: (2021)

The adaptive strategies of cells in the face of CIN
por: Storchová, Zuzana
Publicado: (2023)

Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology
por: Al-Shibli, Khalid, et al.
Publicado: (2022)

PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer
por: Vidal, A. C., et al.
Publicado: (2013)

E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective
por: Origoni, Massimo, et al.
Publicado: (2015)

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
por: Kim, Tae Jin, et al.
Publicado: (2014)

Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2–3: A narrative review
por: Desravines, Nerlyne, et al.
Publicado: (2020)

Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions
por: Terry, G, et al.
Publicado: (2002)

Pathways of IFN-alpha Activation in Patients with Cervical Intraepithelial Neoplasia (CIN)
por: Tirone, Nelson Ranieri, et al.
Publicado: (2021)

Aberrant frequency of TNFR2(+) Treg and related cytokines in patients with CIN and cervical cancer
por: Zhang, Teng, et al.
Publicado: (2017)

Overexpression of programmed cell death ligand 1 in patients with CIN and its correlation with human papillomavirus infection and CIN persistence
por: Sancakli Usta, Ceyda, et al.
Publicado: (2020)

The progress in our understanding of CIN in breast cancer research
por: Liao, Yu-Yang, et al.
Publicado: (2023)

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?
por: Austin, R. Marshall, et al.
Publicado: (2014)

HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry
por: Zheng, Qiaoli, et al.
Publicado: (2021)

p53 hides a multitude of CIN
por: Short, Ben
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2kql0es8s23nucd5m85s74pou1